Home › Funds › JPMorgan › JPMorgan Healthcare Leaders ETF
Fund family: JPMorgan · Filed by J.P. Morgan Exchange-Traded Fund Trust (CIK 1485894) · SEC series S000080528
Ticker: JDOC (C000243005)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 617 with, 16 against, 0 abstentions (not counted as with management); 26 items carried no recommendation. Shareholder proposals: 4 FOR, 16 AGAINST, 1 abstained, by the filing’s own vote-source field.
The same two figures as JPMorgan’s manager page (270,893 ballot items across 111 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | JPMorgan | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 98.8% | 576 | 93.4% | 220,206 |
| Backed environmental and social shareholder proposals at US companies | n/a | 5 | 5.5% | 2,647 |
Each ballot item this fund voted is set against the votes of the other JPMorgan funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most JPMorgan funds on all 586 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 67.3% of this fund’s 633 such votes could be given a sector; the other 207 (32.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 367 | 15 | 4.1% |
| Industrials | 42 | 0 | 0.0% |
| Consumer Staples | 17 | 1 | 5.9% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 406 | 0 |
| Corporate Governance | 61 | 11 |
| Audit-related | 56 | 0 |
| Say-on-Pay | 53 | 0 |
| Capital Structure | 41 | 0 |
| Compensation | 30 | 0 |
| Other Social Issues | 6 | 4 |
| Other | 4 | 0 |
| Shareholder Rights and Defenses | 3 | 0 |
| Extraordinary Transactions | 2 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| JOHNSON & JOHNSON | April 23, 2026 | $887,269 | 15 | 1 |
| ELI LILLY AND COMPANY | May 4, 2026 | $873,032 | 10 | 2 |
| ABBVIE INC. | May 8, 2026 | $789,341 | 8 | 1 |
| UNITEDHEALTH GROUP INCORPORATED | June 1, 2026 | $556,281 | 12 | 1 |
| MERCK & CO., INC. | May 26, 2026 | $495,848 | 18 | 3 |
| McKesson Corporation | July 30, 2025 | $348,122 | 14 | 0 |
| REGENERON PHARMACEUTICALS, INC. | June 12, 2026 | $327,626 | 7 | 0 |
| BRISTOL-MYERS SQUIBB COMPANY | May 5, 2026 | $303,434 | 15 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| April 23, 2026 | JOHNSON & JOHNSON | Independent Board Chair Shareholder proposal | Against | For |
| May 4, 2026 | ELI LILLY AND COMPANY | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | Against | For |
| May 4, 2026 | ELI LILLY AND COMPANY | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| May 8, 2026 | ABBVIE INC. | Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposal | Against | For |
| June 1, 2026 | UNITEDHEALTH GROUP INCORPORATED | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | Against | For |
| May 26, 2026 | MERCK & CO., INC. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | MERCK & CO., INC. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| May 5, 2026 | BRISTOL-MYERS SQUIBB COMPANY | Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Shareholder proposal | Against | For |
| May 14, 2026 | CVS HEALTH CORPORATION | Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposal | Against | For |
| May 13, 2026 | VERTEX PHARMACEUTICALS INCORPORATED | Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposal | Against | For |
| April 23, 2026 | IQVIA HOLDINGS INC. | If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles. Shareholder proposal | Against | For |
| April 30, 2026 | BOSTON SCIENTIFIC CORPORATION | Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." Shareholder proposal | Against | For |
663 ballot items at 60 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, JPMorgan Healthcare Leaders ETF (JDOC) voted at 60 shareholder meetings of 56 companies, on 663 ballot items in all. Where management made a recommendation, the fund followed it on 97.5% of the items and voted against it 16 times. Its most frequent area of disagreement was corporate governance (11 of its votes against management). It voted on 21 shareholder proposals. It voted FOR the board's own proposals more often than JPMorgan's funds as a whole (98.8% against 93.4%). It voted the same way as most JPMorgan funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of JPMorgan’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.